AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Serratiopeptidase
4 registrations across 3 African markets— 4 active
Markets with Serratiopeptidase
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Peptiase Tablet Tablet | 🇳🇬Nigeria | Chanrai HealthCare Limited | active | Oct 2026 |
| BellBag Serratiopeptidase Tablets** Tablet | 🇳🇬Nigeria | BellBag Pharmaceuticals Ltd | active | Nov 2025 |
| Serrata Tablets | 🇹🇿Tanzania | Kusum Healthcare Pvt. Ltd | active | — |
| ENZOKAP Film-Coated Tablet | 🇰🇪Kenya | ACCRA PHARMACY LTD | active | — |
Serratiopeptidase in Africa — Regulatory Overview
Serratiopeptidase is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 4 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.